Compared with treatment with only 90 Y–transarterial radioembolization (TARE), adding microbubble-based radiosensitization via ultrasound-triggered microbubble destruction to 90 Y-TARE had similar safety, provided improved treatment response, and prolonged survival in participants with hepatocellular carcinoma.
Wessner et al. (Mon,) studied this question.